Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to evaluate the performance of muscle ultrasound sections on antenatal ultrasound between 21-24 amenorrhea weeks for the screening of muscle atrophy, in a sample of low-risk and high-risk pregnancies of congenital multiple arthrogryposis


Clinical Trial Description

Frequent rare diseases (100-200 births in France / year), congenital multiple arthrogryposis include a set of pathologies characterized by the limitation of joint movements at least two joint levels.Their functional prognosis and muscle atrophy are often severe after birth. Routine ultrasound call signs are either non-specific or insensitive and difficult to detect due to time constraints. Antenatal ultrasound screening is not very effective for these pathologies, which are often particularly serious. The main criterion will be the success rate of realization of all four ultrasound sections at the extremities (deltoide, biceps, quadriceps, triceps) and measurements of the distances "skin - muscle fascia" and "muscular fascia - periosteum" between 21-24 amenorrhea weeks ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06130592
Study type Interventional
Source University Hospital, Grenoble
Contact Lora PEJOT, Midwife
Phone 0476766561
Email lpejot@chu-grenoble.fr
Status Not yet recruiting
Phase N/A
Start date January 1, 2024
Completion date February 1, 2025